Market Tracker

02/05 5:16pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.44
Delayed Data
As of Feb 05
 -0.04 / -1.61%
Today’s Change
1.63
Today|||52-Week Range
26.25
+20.79%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close2.48
Today’s open2.44
Day’s range2.42 - 2.52
Volume12,068
Average volume (3 months)30,307
Market cap$8.5M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+26.19%
Earnings growth (this year)+19.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-69.69%
P/E ratioNM
Price/Sales29.66
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
GNVCGenVec Inc-0.00-0.39%
RTTRRitter Pharmaceutica...-0.09-6.72%
ECTEEcho Therapeutics In...-0.10-10.00%
CPHIChina Pharma Holding...+0.00+1.39%
Data as of 3:59pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$31.25
Annual revenue (last year)$1.1M
Annual profit (last year)-$15.2M
Net profit margin-1,441.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts